民族
慢性肝炎
抗病毒治疗
丙型肝炎
医学
乙型肝炎
内科学
病毒学
政治学
病毒
法学
作者
Sahith Kudaravalli,Daniel Q. Huang,Ming-Lun Yeh,Lindsey Trinh,P C Tsai,Yao‐Chun Hsu,Leslie Y. Kam,Vy H. Nguyen,Eiichi Ogawa,Dong Hyun Lee,Takanori Ito,Tsunamasa Watanabe,Masaru Enomoto,Carmen Monica Preda,Michael Ko,Rex Wan-Hin Hui,Masanori Atsukawa,Takanori Suzuki,Sebastián Marciano,Ana Barreira
标识
DOI:10.1016/j.jhep.2024.02.033
摘要
Oral antiviral therapy with nucleos(t)ide analogues (NAs) for chronic hepatitis B (CHB) is well-tolerated and lifesaving, but real-world data on utilization are limited. We examined rates of evaluation and treatment in patients from the REAL-B consortium.
科研通智能强力驱动
Strongly Powered by AbleSci AI